Advanced Search
Disease Phase
Title Drug
Clinical Trials Listing
  • < Previous
  • 1
  • Next >
  • Penn Treatment Trials (2)
  • Penn Non-Treatment Trials (7)
  • Phase 1: Solid Tumor Trials (2)
  • Proton Therapy Trials (1)
Active treatment trials at Penn's Abramson Cancer Center
Protocol ID Title Phase Modality Drug
HPV-003 Phase II Placebo Controlled Study of VGX-3100, (HPV16 E6/E7, HPV18 E6/E7 DNA Vaccine) Delivered IM Followed by Electroporation With Cellectra-5P for the Treatment of Biopsy-proven CIN 2/3 or CIN 3 With Documented HPV 16 or 18. II Immunotherapy Not Applicable
CA186-011 A Phase 1 Study of the Safety, Tolerability, Pharmacokinetics and Immunoregulatory Activity of BMS-663513 (Anti-CD137) in Subjects With Advanced and/or Metastatic Solid Tumors I Immunotherapy BMS-663513
Displaying: 1 - 2 of 2 Results
  • < Previous
  • 1
  • Next >